{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T05:06:05Z","timestamp":1789016765520,"version":"build-2803163510"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.ejpb.2019.07.012","type":"journal-article","created":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T11:32:20Z","timestamp":1562931140000},"page":"387-395","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Effects of absorption-modifying excipients on jejunal drug absorption in simulated fasted and fed luminal conditions"],"prefix":"10.1016","volume":"142","author":[{"given":"C.","family":"Roos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Dahlgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Sj\u00f6gren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Sj\u00f6blom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hedeland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Lennern\u00e4s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejpb.2019.07.012_b0005","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1056-8719(00)00107-6","article-title":"Drug-like properties and the causes of poor solubility and poor permeability","volume":"44","author":"Lipinski","year":"2000","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.ejpb.2019.07.012_b0010","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.addr.2016.03.013","article-title":"Cell permeability beyond the rule of 5","volume":"101","author":"Matsson","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"6","key":"10.1016\/j.ejpb.2019.07.012_b0015","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.copbio.2007.10.005","article-title":"Drug discovery beyond the \u2018rule-of-five\u2019","volume":"18","author":"Zhang","year":"2007","journal-title":"Curr. Opin. Biotechnol."},{"issue":"1","key":"10.1016\/j.ejpb.2019.07.012_b0020","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1021\/mp034006h","article-title":"Molecular properties of WHO essential drugs and provisional biopharmaceutical classification","volume":"1","author":"Kasim","year":"2004","journal-title":"Mol. Pharm."},{"issue":"3","key":"10.1016\/j.ejpb.2019.07.012_b0025","first-page":"82","article-title":"Poor aqueous solubility\u2014an industry wide problem in drug discovery","volume":"5","author":"Lipinski","year":"2002","journal-title":"Am. Pharm. Rev."},{"issue":"3","key":"10.1016\/j.ejpb.2019.07.012_b0030","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1023\/A:1016212804288","article-title":"A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability","volume":"12","author":"Amidon","year":"1995","journal-title":"Pharm. Res."},{"issue":"4","key":"10.1016\/j.ejpb.2019.07.012_b0035","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.xphs.2016.12.002","article-title":"Optimizing oral bioavailability in drug discovery: an overview of design and testing strategies and formulation options","volume":"106","author":"Aungst","year":"2017","journal-title":"J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.ejpb.2019.07.012_b0040","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/(SICI)1520-6017(200004)89:4<429::AID-JPS1>3.0.CO;2-J","article-title":"Intestinal permeation enhancers","volume":"89","author":"Aungst","year":"2000","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2019.07.012_b0045","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.addr.2016.06.005","article-title":"Intestinal permeation enhancers for oral peptide delivery","volume":"106","author":"Maher","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"15","key":"10.1016\/j.ejpb.2019.07.012_b0050","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.addr.2009.09.006","article-title":"Safety and efficacy of sodium caprate in promoting oral drug absorption: from in vitro to the clinic","volume":"61","author":"Maher","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"6","key":"10.1016\/j.ejpb.2019.07.012_b0055","doi-asserted-by":"crossref","first-page":"883","DOI":"10.7326\/0003-4819-105-6-883","article-title":"Increased intestinal permeability in patients with Crohn's disease and their relatives: a possible etiologic factor","volume":"105","author":"Hollander","year":"1986","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ejpb.2019.07.012_b0060","article-title":"The effects of three absorption-modifying critical excipients on the in vivo intestinal absorption of six model compounds in rats and dogs","author":"David","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2019.07.012_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2018.07.057","article-title":"Effect of absorption-modifying excipients, hypotonicity, and enteric neural activity in an in vivo model for small intestinal transport","author":"Dahlgren","year":"2018","journal-title":"Int. J. Pharm."},{"issue":"12","key":"10.1016\/j.ejpb.2019.07.012_b0070","doi-asserted-by":"crossref","first-page":"4243","DOI":"10.1021\/acs.molpharmaceut.7b00353","article-title":"Preclinical effect of absorption modifying excipients on rat intestinal transport of model compounds and the mucosal barrier marker 51Cr-EDTA","volume":"14","author":"Dahlgren","year":"2017","journal-title":"Mol. Pharm."},{"issue":"3","key":"10.1016\/j.ejpb.2019.07.012_b0075","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1046\/j.1365-201x.1999.00510.x","article-title":"Jejunal permeability in humans in vivo and rats in situ: investigation of molecular size selectivity and solvent drag","volume":"165","author":"Fagerholm","year":"1999","journal-title":"Acta Physiol. Scand."},{"issue":"12","key":"10.1016\/j.ejpb.2019.07.012_b0080","doi-asserted-by":"crossref","first-page":"4252","DOI":"10.1021\/acs.molpharmaceut.7b00279","article-title":"Regional intestinal permeability in rats: a comparison of methods","volume":"14","author":"Roos","year":"2017","journal-title":"Mol. Pharm."},{"issue":"8","key":"10.1016\/j.ejpb.2019.07.012_b0085","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1007\/s11095-006-9041-2","article-title":"Why is it challenging to predict intestinal drug absorption and oral bioavailability in human using rat model","volume":"23","author":"Cao","year":"2006","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.ejpb.2019.07.012_b0090","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejpb.2005.07.008","article-title":"Enhancement of intestinal absorption of poorly absorbed hydrophilic compounds by simultaneous use of mucolytic agent and non-ionic surfactant","volume":"62","author":"Takatsuka","year":"2006","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2019.07.012_b0095","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ejps.2014.11.010","article-title":"Evaluation of fasted state human intestinal fluid as apical solvent system in the Caco-2 absorption model and comparison with FaSSIF","volume":"67","author":"Wuyts","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"issue":"5","key":"10.1016\/j.ejpb.2019.07.012_b0100","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1021\/mp100049m","article-title":"Dissolution rate and apparent solubility of poorly soluble drugs in biorelevant dissolution media","volume":"7","author":"Fagerberg","year":"2010","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2019.07.012_b0105","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ejps.2013.08.027","article-title":"A review of drug solubility in human intestinal fluids: implications for the prediction of oral absorption","volume":"57","author":"Augustijns","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"issue":"11","key":"10.1016\/j.ejpb.2019.07.012_b0110","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1111\/j.2042-7158.2010.01023.x","article-title":"Characterising the behaviour of poorly water soluble drugs in the intestine: application of biorelevant media for solubility, dissolution and transport studies","volume":"62","author":"Kleberg","year":"2010","journal-title":"J. Pharm. Pharmacol."},{"issue":"5","key":"10.1016\/j.ejpb.2019.07.012_b0115","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1023\/A:1011910801212","article-title":"Evaluation of various dissolution media for predicting in vivo performance of class I and II drugs","volume":"15","author":"Galia","year":"1998","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2019.07.012_b0120","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ejps.2018.02.032","article-title":"Evaluation of drug permeation under fed state conditions using mucus-covered Caco-2 cell epithelium","volume":"118","author":"Birch","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2019.07.012_b0125","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ejpb.2018.09.022","article-title":"Jejunal absorption of aprepitant from nanosuspensions: role of particle size, prandial state and mucus layer","volume":"132","author":"Roos","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"2","key":"10.1016\/j.ejpb.2019.07.012_b0130","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s11095-008-9750-9","article-title":"Colloidal structures in media simulating intestinal fed state conditions with and without lipolysis products","volume":"26","author":"Fatouros","year":"2009","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.ejpb.2019.07.012_b0135","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/jps.2600710120","article-title":"Theoretical and experimental studies of transport of micelle-solubilized solutes","volume":"71","author":"Amidon","year":"1982","journal-title":"J. Pharm. Sci."},{"issue":"12","key":"10.1016\/j.ejpb.2019.07.012_b0140","doi-asserted-by":"crossref","first-page":"4233","DOI":"10.1021\/acs.molpharmaceut.7b00294","article-title":"In vivo mechanisms of intestinal drug absorption from aprepitant nanoformulations","volume":"14","author":"Roos","year":"2017","journal-title":"Mol. Pharm."},{"issue":"6","key":"10.1016\/j.ejpb.2019.07.012_b0145","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1023\/A:1018965328626","article-title":"Evidence for an interaction between the \u03b2-blocker pafenolol and bile salts in the intestinal lumen of the rat leading to dose-dependent oral absorption and double peaks in the plasma concentration\u2013time profile","volume":"10","author":"Lennern\u00e4s","year":"1993","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2019.07.012_b0150","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ejpb.2018.10.006","article-title":"Mechanistic modelling of intestinal drug absorption\u2013The in vivo effects of nanoparticles, hydrodynamics, and colloidal structures","volume":"133","author":"Roos","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"4","key":"10.1016\/j.ejpb.2019.07.012_b0155","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1748-1716.2006.01649.x","article-title":"Modulation of mucosal permeability by vasoactive intestinal peptide or lidocaine affects the adjustment of luminal hypotonicity in rat duodenum","volume":"189","author":"Nylander","year":"2007","journal-title":"Acta Physiol."},{"issue":"1","key":"10.1016\/j.ejpb.2019.07.012_b0160","doi-asserted-by":"crossref","first-page":"G95","DOI":"10.1152\/ajpgi.00074.2013","article-title":"Melatonin inhibits alcohol-induced increases in duodenal mucosal permeability in rats in vivo","volume":"305","author":"Sommansson","year":"2013","journal-title":"Am. J. Physiol.-Gastrointest. Liver Physiol."},{"issue":"6","key":"10.1016\/j.ejpb.2019.07.012_b0165","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1021\/mp500834v","article-title":"Human in vivo regional intestinal permeability: quantitation using site-specific drug absorption data","volume":"12","author":"Sj\u00f6gren","year":"2015","journal-title":"Mol. Pharm."},{"issue":"8","key":"10.1016\/j.ejpb.2019.07.012_b0170","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1023\/A:1018984731584","article-title":"Intestinal permeability enhancement: efficacy, acute local toxicity, and reversibility","volume":"11","author":"Swenson","year":"1994","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2019.07.012_b0175","first-page":"25","article-title":"Studies of intestinal absorption under pathological conditions. I. Light microscopic studies of intestinal damage caused by sodium lauryl sulfate","volume":"16","author":"Sugimura","year":"1974","journal-title":"Nihon Univ. J. Med"},{"issue":"1","key":"10.1016\/j.ejpb.2019.07.012_b0180","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.prrv.2007.02.009","article-title":"Mucolytics in cystic fibrosis","volume":"8","author":"Henke","year":"2007","journal-title":"Paediatr. Respir. Rev."},{"issue":"9","key":"10.1016\/j.ejpb.2019.07.012_b0185","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1002\/jps.20691","article-title":"Effect of food intake on the oral absorption of poorly water-soluble drugs: in vitro assessment of drug dissolution and permeation assay system","volume":"95","author":"Kataoka","year":"2006","journal-title":"J. Pharm. Sci."},{"issue":"5","key":"10.1016\/j.ejpb.2019.07.012_b0190","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1021\/mp200181v","article-title":"The solubility\u2013permeability interplay: mechanistic modeling and predictive application of the impact of micellar solubilization on intestinal permeation","volume":"8","author":"Miller","year":"2011","journal-title":"Mol. Pharm."},{"issue":"19","key":"10.1016\/j.ejpb.2019.07.012_b0195","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1002\/1522-2683(200210)23:19<3381::AID-ELPS3381>3.0.CO;2-4","article-title":"Method for immobilization of liposomes in capillary electrophoresis by electrostatic interaction with derivatized agarose","volume":"23","author":"\u00d6rnskov","year":"2002","journal-title":"Electrophoresis"},{"issue":"9","key":"10.1016\/j.ejpb.2019.07.012_b0200","doi-asserted-by":"crossref","first-page":"5803","DOI":"10.1016\/S0021-9258(18)91085-9","article-title":"The beta-adrenergic receptor survives solubilization in deoxycholate while forming a stable association with the agonist","volume":"259","author":"Nedivi","year":"1984","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.ejpb.2019.07.012_b0205","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/j.bbamem.2015.12.014","article-title":"Molecular simulation of nonfacilitated membrane permeation","volume":"1858","author":"Awoonor-Williams","year":"2016","journal-title":"Biochim. Biophys. Acta (BBA)-Biomembr."},{"issue":"7","key":"10.1016\/j.ejpb.2019.07.012_b0210","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1021\/mp500776a","article-title":"Interaction with mixed micelles in the intestine attenuates the permeation enhancing potential of alkyl-maltosides","volume":"12","author":"Gradauer","year":"2015","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.ejpb.2019.07.012_b0215","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.colsurfb.2006.01.001","article-title":"Kinetic studies of the interaction of fatty acids with phosphatidylcholine vesicles (liposomes)","volume":"48","author":"Rogerson","year":"2006","journal-title":"Colloids Surf., B"},{"issue":"9","key":"10.1016\/j.ejpb.2019.07.012_b0220","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1021\/acs.molpharmaceut.6b00515","article-title":"Regional intestinal permeability in dogs: biopharmaceutical aspects for development of oral modified-release dosage forms","volume":"13","author":"Dahlgren","year":"2016","journal-title":"Mol. Pharm."},{"issue":"10\u201311","key":"10.1016\/j.ejpb.2019.07.012_b0225","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1080\/00498250701704819","article-title":"Intestinal permeability and its relevance for absorption and elimination","volume":"37","author":"Lennernas","year":"2007","journal-title":"Xenobiotica"},{"issue":"4","key":"10.1016\/j.ejpb.2019.07.012_b0230","doi-asserted-by":"crossref","first-page":"G653","DOI":"10.1152\/ajpgi.1989.257.4.G653","article-title":"Effects of hydrochloric acid on duodenal and jejunal mucosal permeability in the rat","volume":"257","author":"Nylander","year":"1989","journal-title":"Am. J. Physiol.-Gastrointest. Liver Physiol."},{"key":"10.1016\/j.ejpb.2019.07.012_b0235","doi-asserted-by":"crossref","DOI":"10.1124\/dmd.109.026591","article-title":"Intestinal perfusion with mesenteric blood sampling in wild-type and knockout mice: evaluation of a novel tool in biopharmaceutical drug profiling","author":"Mols","year":"2009","journal-title":"Drug Metab. Dispos."},{"issue":"7","key":"10.1016\/j.ejpb.2019.07.012_b0240","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jps.2600790710","article-title":"Epithelial transport of drugs in cell culture. II: Effect of extracellular calcium concentration on the paracellular transport of drugs of different lipophilicities across monolayers of intestinal epithelial (Caco-2) cells","volume":"79","author":"Artursson","year":"1990","journal-title":"J. Pharm. Sci."},{"issue":"5","key":"10.1016\/j.ejpb.2019.07.012_b0245","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/cpt1976205524","article-title":"Clinical pharmacologic observations on atenolol, a beta-adrenoceptor blocker","volume":"20","author":"Brown","year":"1976","journal-title":"Clin. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.ejpb.2019.07.012_b0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbamem.2005.07.009","article-title":"Behaviour of small solutes and large drugs in a lipid bilayer from computer simulations","volume":"1718","author":"Bemporad","year":"2005","journal-title":"Biochim. Biophys. Acta (BBA)-Biomembr."},{"issue":"6","key":"10.1016\/j.ejpb.2019.07.012_b0255","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1021\/mp400713v","article-title":"Passive lipoidal diffusion and carrier-mediated cell uptake are both important mechanisms of membrane permeation in drug disposition","volume":"11","author":"Smith","year":"2014","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.ejpb.2019.07.012_b0260","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1748-1716.1991.tb09206.x","article-title":"Characterization of 51Cr-EDTA as a marker of duodenal mucosal permeability","volume":"143","author":"Nylander","year":"1991","journal-title":"Acta Physiol."},{"issue":"9","key":"10.1016\/j.ejpb.2019.07.012_b0265","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/jps.2600810908","article-title":"Epithelial transport of drugs in cell culture. VII: Effects of pharmaceutical surfactant excipients and bile acids on transepithelial permeability in monolayers of human intestinal epithelial (Caco-2) cells","volume":"81","author":"Anderberg","year":"1992","journal-title":"J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.ejpb.2019.07.012_b0270","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/jps.2600820412","article-title":"Epithelial transport of drugs in cell culture. VIII: Effects of sodium dodecyl sulfate on cell membrane and tight junction permeability in human intestinal epithelial (Caco-2) cells","volume":"82","author":"Anderberg","year":"1993","journal-title":"J. Pharm. Sci."},{"issue":"5","key":"10.1016\/j.ejpb.2019.07.012_b0275","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.ejps.2008.08.004","article-title":"Comparison of drug transporter gene expression and functionality in Caco-2 cells from 10 different laboratories","volume":"35","author":"Hayeshi","year":"2008","journal-title":"Eur. J. Pharm. Sci."},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2019.07.012_b0280","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0168-3659(96)01353-3","article-title":"Enhancement of the intestinal absorption of peptides and nonpeptides","volume":"41","author":"Aungst","year":"1996","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.ejpb.2019.07.012_b0285","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0022-3565(25)38218-2","article-title":"In vitro effects of long-chain acylcarnitines on the permeability, transepithelial electrical resistance and morphology of rat colonic mucosa","volume":"265","author":"Lecluyse","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"11","key":"10.1016\/j.ejpb.2019.07.012_b0290","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1248\/cpb.31.4161","article-title":"Effect of pharmaceutical adjuvants on the rectal permeability of drugs. III. Effect of repeated administration and recovery of the permeability","volume":"31","author":"Nakanishi","year":"1983","journal-title":"Chem. Pharm. Bull."},{"issue":"8","key":"10.1016\/j.ejpb.2019.07.012_b0295","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1248\/bpb1978.8.661","article-title":"Effect of synthetic surfactants on drug absorption in the presence of a physiologic surfactant, sodium taurocholate, in rats","volume":"8","author":"Kimura","year":"1985","journal-title":"J. Pharmacobiodyn."},{"issue":"3","key":"10.1016\/j.ejpb.2019.07.012_b0300","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/0016-5085(89)90897-4","article-title":"Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability","volume":"96","author":"Hidalgo","year":"1989","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejpb.2019.07.012_b0305","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ijpharm.2018.05.029","article-title":"The effects of three absorption-modifying critical excipients on the in vivo intestinal absorption of six model compounds in rats and dogs","volume":"547","author":"Dahlgren","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2019.07.012_b0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2018.09.001","article-title":"Time-dependent effects on small intestinal transport by absorption-modifying excipients","author":"Dahlgren","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093964111930520X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093964111930520X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:38:50Z","timestamp":1760546330000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S093964111930520X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":62,"alternative-id":["S093964111930520X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2019.07.012","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of absorption-modifying excipients on jejunal drug absorption in simulated fasted and fed luminal conditions","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2019.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}